Mysore V. Tejesvi

Dr. Mysore V. Tejesvi

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TTTerhi Tapiainen
Terhi Tapiainen
PKPirjo Koivusaari
Pirjo Koivusaari
LBLauren Brinkac
Lauren Brinkac
HLHernan A Lorenzi
Hernan A Lorenzi
JSJarmo Salo
Jarmo Salo
MTMysore V. Tejesvi
Mysore V. Tejesvi
Altogether, 20–30% of women receive intrapartum antibiotic prophylaxis (IAP) to prevent sepsis in infants and 2–5% of newborn infants receive antibiotics due to suspected sepsis. Caesarean section has a long-term impact on the intestinal microbiome but the effects of perinatal antibiotics on gut microbiome in vaginally delivered infants are not well known. We compared the impact of IAP, postnatal antibiotics, or their combination on the gut microbiome and emergence of antimicrobial resistance in a controlled study of 149 newborn infants recruited within 24 hours after birth. We collected 659 fecal samples, including 426 daily samples from infants before discharge from the hospital and 111 follow-up samples at six months. Penicillin was mostly used for IAP and the combination of penicillin and aminoglycoside for postnatal treatment. Postnatal antibiotic groups received Lactobacillus reuteri probiotic. Newborn gut colonization differed in both IAP and postnatal antibiotics groups as compared to that in control group. The effect size of IAP was comparable to that caused by postnatal antibiotics. The observed differences were still present at six months and not prevented by lactobacilli consumption. Given the present clinical results, the impact of perinatal antibiotics on the subsequent health of newborn infants should be further evaluated.

18 January 2011 in Fungal Diversity
Verified
Journal Article
Closed access
PDF file
MTMysore V. Tejesvi
Mysore V. Tejesvi
MKMarena Kajula
Marena Kajula
SMSampo Mattila
Sampo Mattila
APAnna Maria Pirttilä
Anna Maria Pirttilä
Eighty-seven endophytic fungi were isolated from asymptomatic leaf tissues of Rhododendron tomentosum. Most of the isolates were non-sporulating and therefore difficult to identify exclusively based on morphological characters. Eighteen isolates that were morphologically distinct were selected for identification by sequencing the ITS region. For culture-independent analysis, the DNA was isolated from the surface-sterilized leaves of R. tomentosum and the ITS region was amplified using fungal specific primers ITS1F and ITS4, cloned, and 11 clones were randomly selected and sequenced. The phylogenetic analysis was performed with MEGA4 on a total of 49 sequences, including 18 endophytic isolates and 11 unculturables obtained in this study, and 20 sequences from Genbank, which were distributed in four clusters. The culturable and unculturable endophytes formed separate clades and were clearly distinguishable with no overlap within the groups. Endophytic fungi are a well-recognized source of bioactive compounds and therefore antibacterial and antioxidant activities of the isolates of R. tomentosum were studied. All isolates were grown in two different media, enriched (MEB) and depleted (DM), and screened for antibacterial and antioxidant activities. As a result, 10% produced antibacterials and 14% antioxidants, in total 24% of the isolates had biological activity. Antioxidant broth of TRT59 was partially purified using HPLC. The majority of antibacterial compounds were produced in DM media and antioxidants in MEB media. Therefore, it is advisable to test various media for production of antibacterials and antioxidants.

30 December 2015 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
MTMysore V. Tejesvi
Mysore V. Tejesvi
MAM. Arvonen
M. Arvonen
SKSalla M Kangas
Salla M Kangas
PKP. L. Keskitalo
P. L. Keskitalo
APAnna Maria Pirttilä
Anna Maria Pirttilä
PVP. Vähäsalo
P. Vähäsalo

1 April 2014 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
MEMahmoud Fahmi Elsebai
Mahmoud Fahmi Elsebai
MSMuhammad Saleem
Muhammad Saleem
MTMysore V. Tejesvi
Mysore V. Tejesvi
MKMarena Kajula
Marena Kajula
SMSampo Mattila
Sampo Mattila
APAnna Maria Pirttilä
Anna Maria Pirttilä
Covering up to the end of August 2013 Phenalenones are members of a unique class of natural polyketides exhibiting diverse biological potential. This is a comprehensive review of 72 phenalenones with diverse structural features originating from fungal sources. Their bioactive potential and structure elucidation are discussed along with a review of their biosynthetic pathways and the taxonomical relationship between the fungi producing these natural products.

1 December 2005 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MTMysore V. Tejesvi
Mysore V. Tejesvi
BMBasavanna Mahesh
Basavanna Mahesh
MNMonnanda S. Nalini
Monnanda S. Nalini
HPHarischandra S. Prakash
Harischandra S. Prakash
KKKukkundoor R. Kini
Kukkundoor R. Kini
HSHunthrike S. Shetty
Hunthrike S. Shetty

13 July 2018 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
NPNiko Paalanne
Niko Paalanne
AHAleksi Husso
Aleksi Husso
JSJarmo Salo
Jarmo Salo
OPOskari Pieviläinen
Oskari Pieviläinen
MTMysore V. Tejesvi
Mysore V. Tejesvi
TTTerhi Tapiainen
Terhi Tapiainen